![]() | ||
5.11.2017 | AGENDA | |
. | ||
12:30 – 1:30 | Registration & Networking | |
1:30 – 1:40 | Welcome & Opening Remarks Bob Buderi, Founder & CEO, Xconomy Paul McKenzie, EVP for Pharmaceutical Operations and Technology, Biogen | |
1:40 – 2:10 | Standing Up for Immigration and Diversity in Biotech Tony Coles, Chairman & CEO, Yumanity Therapeutics Susan Windham-Bannister, President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries Teresa Lavoie, Partner, Fish & Richardson (moderator) | |
2:10 – 2:35 | The Life Sciences in 2017 and Beyond: An Interactive Chat Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis Bob Buderi, Founder & CEO, Xconomy | |
2:35 – 3:05 | Battling the Opioid Crisis Richard Pops, Chairman & CEO, Alkermes Peter Koutoujian, Sheriff of Middlesex County, former member, Massachusetts House of Representatives | |
3:05 – 3:35 | Patient-Centric Drug Development Ed Kaye, President & CEO, Sarepta Therapeutics Peter Saltonstall, President & CEO, National Organization for Rare Disorders Abbie Celniker, Partner, Third Rock Ventures (moderator) | |
3:35 – 4:05 | Break | |
4:05 – 4:25 | Pioneering Life Science Ventures Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering | |
4:25 – 5:00 | Translating Science and Company Building: A Chat With Two Serial Entrepreneurs Michael Gilman, CEO & Chairman, Arrakis Therapeutics Katrine Bosley, CEO, Editas Medicine | |
5:00 – 5:30 | Cancer Therapies of the Future Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute David Schenkein, CEO, Agios Pharmaceuticals | |
5:30 – 6:30 | Networking Reception |
*Schedule is subject to change.
Join us on May 11, register now.